Cite
HARVARD Citation
Wagner, L. et al. (n.d.). Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors. Pediatric blood & cancer. 60 (9), pp. 1447-1451. [Online].